共 178 条
[3]
Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
[J].
MULTIPLE SCLEROSIS JOURNAL,
2019, 25 (02)
:235-245
[9]
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis
[J].
JOURNAL OF AUTOIMMUNITY,
2004, 22 (04)
:353-362